Genmab — Februar 2021
-
"Der er så stille nu"...måske stilhed før storm:-)
-
ADS US under 40
-
God morgen.

-
Asien: Kursfald i takt med drop i amerikanske indeksfutures - NY:
https://www.proinvestor.com/investornyt/671766/asien-kursfald-i-takt-med-drop-i-amerikanske-indeksfutures-ny -
Torsdagens aviser med Novo Nordisk, Ørsted og Ringkjøbing Landbobank: https://www.proinvestor.com/investornyt/671763/torsdagens-aviser-med-novo-nordisk-orsted-og-ringkjobing-landbobank
-
Aktier/tendens: Nordea står til belønning på ny regnskabstung dag: https://www.proinvestor.com/investornyt/671776/aktier-tendens-nordea-star-til-belonning-pa-ny-regnskabstung-dag
-
AbbVie (ABBV) Q4 2020 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2021/02/03/abbvie-abbv-q4-2020-earnings-call-transcript/
-
Det kalder man base-dannelse. Er sundt for aktiekursen på den lange bane.

-
Roche https://www.roche.com/dam/jcr:e9d85f10-5ba5-4e8b-9535-eb8246b11641/en/irp210204.pdf Ritxan svigter nu. Ocrevus 4,3 bn CHF. Og meget mere læsestof.
-
Umiddelbart holder TA omkring 2480, så kan Jan ellers slå vores sokker af med guide 2021 - jeg er klar med de lange skistrømper.
-
ADC Therapeutics Completes Enrollment in Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) in Relapsed or Refractory Hodgkin Lymphoma https://www.businesswire.com/news/home/20210204005392/en/ADC-Therapeutics-Completes-Enrollment-in-Pivotal-Phase-2-Clinical-Trial-of-Camidanlumab-Tesirine-Cami-in-Relapsed-or-Refractory-Hodgkin-Lymphoma
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind